Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:


Generated: August 20, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Which drugs does patent 5,969,156 protect, and when does it expire?

Patent ► Subscribe protects LIPITOR, CADUET, and LIPTRUZET, and is included in three NDAs. There have been three Paragraph IV challenges on Caduet.

Protection for LIPITOR has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has sixty-four patent family members in thirty-six countries.

Summary for Patent: ► Subscribe

Title: Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)
Abstract:Crystalline forms of atorvastatin and hydrates thereof are useful hypolipidemic and hypocholesterolemic agents.
Inventor(s): Briggs; Christopher A. (Holland, MI), Jennings; Rex A. (Holland, MI), Wade; Robert (Holland, MI), Harasawa; Kikuko (Sagamihara, JP), Ichikawa; Shigeru (Machida, JP), Minohara; Kazuo (Sagamihara, JP), Nakagawa; Shinsuke (Sagamihara, JP)
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Application Number:08/945,812
Patent Claim Types:
see list of patent claims

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
atorvastatin calcium
TABLET;ORAL020702-001Dec 17, 1996ABRXYesNo► Subscribe► SubscribeY
atorvastatin calcium
TABLET;ORAL020702-002Dec 17, 1996ABRXYesNo► Subscribe► SubscribeY
atorvastatin calcium
TABLET;ORAL020702-003Dec 17, 1996ABRXYesNo► Subscribe► SubscribeY
atorvastatin calcium
TABLET;ORAL020702-004Apr 7, 2000ABRXYesYes► Subscribe► SubscribeY
amlodipine besylate; atorvastatin calcium
TABLET;ORAL021540-009Jul 29, 2004ABRXYesNo► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: ► Subscribe

PCT Information
PCT FiledJuly 08, 1996PCT Application Number:PCT/US96/11368
PCT Publication Date:February 06, 1997PCT Publication Number: WO97/03959

International Patent Family for Patent: ► Subscribe

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina003458► Subscribe
Argentina003459► Subscribe
Austria208375► Subscribe
Austria284868► Subscribe
Austria8453► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Johnson and Johnson
US Department of Justice
Chinese Patent Office
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus